Position in ETON
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$3,190,378
+$2,668,396 QoQ
Shares Held
88,132
+316.7% QoQ
Ownership
0.308%
of shares outstanding
% of Portfolio
0.74%
of 13F equity value
Holder Rank
#38
of 164 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 63%
Shared 0%
None 37%
Common Shares in ETON Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Bridge City Capital, LLC holds $24,367,503 across 5 Drug Manufacturers - Specialty & Generic names. ETON ranks #4 (13.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PCRX |
Pacira BioSciences, Inc.
|
312,297 | $7,922,974 | |
| 2 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
338,708 | $6,835,127 | |
| 3 | SUPN |
Supernus Pharmaceuticals, Inc.
|
78,167 | $3,635,547 | |
| 4 | ETON |
Eton Pharmaceuticals, Inc.
This page
|
88,132 | $3,190,378 | |
| 5 | ANIP |
Ani Pharmaceuticals Inc
|
33,625 | $2,783,477 |
All Filings in ETON
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,190,378 | 88,132 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $521,982 | 21,150 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $314,526 | 18,600 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $362,304 | 16,673 | Shares | Sole | 2025-11-12 | |
| No filing history on record for this holder in this stock. | ||||||